Illumina Inc.
9885 Towne Centre Drive
San Diego,
CA 92121
United States - Map
Phone: 858-202-4500
Fax: 858-587-4297
Web Site: http://www.illumina.com
| Illumina, Inc. engages in the development, manufacture, and marketing of integrated systems for the analysis of genetic variation and biological function. Its instrumentation products include Genome Analyzer II, an instrument for high-throughput sequencing using Illumina sequencing by synthesis technology; iScan System, a high-resolution imaging instrument to scan BeadArray based assays; and BeadXpress Reader, a low- to mid-multiplex, high-throughput instrument for readout of assays. The companys consumables comprise Standard Sequencing Kit, a reagent used for sequencing by synthesis chemistry on the Genome Analyzer; Paired-End Genomic DNA Sample Prep Kit, a streamlined library preparation kit to generate 200500 kb insert paired-end reads; InfiniumHD Whole-Genome BeadChips comprising Human1M-Duo, Human610-Quad, Human660W-Quad, and HumanCytoSNP-12, which are multi-sample DNA analysis microarrays that interrogate up to 1.2 million markers per sample; iSelect Custom Genotyping BeadChips that are customer designable SNP genotyping arrays for 6,000 to 200,000 markers; and Whole-Genome Gene Expression BeadChips, which are multi-sample expression profiling arrays with up-to-date content for human, mouse, and rat. Illumina was founded in 1998 and is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Jay Flatley , 56
Chief Exec. Officer, Pres |
$
1.25M |
$
8.38M | Dr. David Walt Ph.D., 56
Founder, Chairman of Scientific Advisory Board, Director and Member of Nominating & Corp. Governance Committee |
$
53.00K | N/A | Mr. Christian O. Henry , 40
Chief Financial Officer, Principal Accounting Officer and Sr. VP of Corp. Devel. |
$
656.00K |
$
2.84M | Mr. Tristan B. Orpin , 43
Sr. VP of Commercial Operations |
$
568.00K |
$
3.25M | Mr. Christian G. Cabou , 60
Sr. VP, Sec. and Gen. Counsel |
$
541.00K |
$
4.03M |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
Profile
